TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›GEV›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

GE Vernova Inc. (GEV) financials

Income statement

GE Vernova Inc. (GEV) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$29.7B$33.2B$34.9B$38.1B
Revenue growth—12.1%5.1%9.0%
Gross profit$3.46B$4.82B$6.08B$7.54B
Gross margin11.7%14.5%17.4%19.8%
Operating income-$2.88B-$923M$471M$1.39B
Operating margin-9.7%-2.8%1.3%3.6%
Net income-$2.74B-$438M$1.55B$4.88B
Net margin-9.2%-1.3%4.4%12.8%
EPS (diluted)-$10.00-$1.60$5.58$17.69

Cash flow

GE Vernova Inc. (GEV) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$114M$1.19B$2.58B$4.99B
Capital expenditures$513M$744M$883M$1.28B
Free cash flow-$627M$442M$1.70B$3.71B
Share buybacks—$0.00$43.0M$3.32B
Dividends paid—$0.00$0.00$275M

Balance sheet

GE Vernova Inc. (GEV) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$2.07B$1.55B$4.20B$8.85B
Total assets—$46.1B$51.5B$63.0B
Total liabilities—$37.7B$40.9B$50.7B
Shareholders' equity$11.6B$7.42B$9.55B$11.2B
Retained earnings—$0.00$1.61B$6.15B
Shares (wtd avg diluted)274M274M274M276M

Every figure is extracted from GE Vernova Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is GE Vernova Inc.'s annual revenue?
GE Vernova Inc. (GEV) reported $38.1B of revenue for fiscal year 2025 — up 9.0% from $34.9B in FY2024, per its annual report filed with the SEC.
Is GE Vernova Inc. profitable?
Yes — GEV earned $4.88B of net income in FY2025, a 12.8% net margin, per SEC filings.
What is GE Vernova Inc.'s free cash flow?
$3.71B in FY2025 (operating cash flow $4.99B minus $1.28B of capital expenditures), from the SEC cash-flow statement.
Does GEV pay a dividend?
Yes — GE Vernova Inc. paid $275M in cash dividends during FY2025, per its SEC cash-flow statement.
Full GEV analysis — verdict, score & filings →Is GEV a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.